Changing Healthcare Procurement Approaches in Canada and Beyond

Similar documents
The Potential Social and Economic Value of Innovation Procurement

Pre-Commercial Procurement (PCP) Actions

OBN BioTuesday: Sources of Public Non-Dilutable Funding & Export Support to UK R&D Companies

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

International comparison of education systems: a European model? Paris, November 2008

OECD s Innovation Strategy: Key Findings and Policy Messages

Canada s Intellectual Property (IP) Strategy submission from Polytechnics Canada

Health Innovations in Horizon 2020: the framework programme for research and innovation ( )

Patenting Strategies. The First Steps. Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1

A review of the role and costs of clinical commissioning groups

Research Development Request - Profile Template. European Commission

Brief to the. Senate Standing Committee on Social Affairs, Science and Technology. Dr. Eliot A. Phillipson President and CEO

TECHNOLOGY WITH A HUMAN TOUCH

ABHI Response to the Kennedy short study on Valuing Innovation

Technology and Innovation in the NHS Scottish Health Innovations Ltd

Alberta Health Services and Advancing Uptake of HTA & Innovation

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

Robotics: from FP7 to Horizon Libor Král, Head of Unit Unit A2 - Robotics DG Communication Networks, Content and Technology European Commission

Public Private Partnerships & Idea selection

The Intellectual Property, Knowledge Transfer: Perspectives

Welcome to Althea. Welcome to the future of integrated healthcare technology management

Innovation in Europe: Where s it going? How does it happen? Stephen Roper Aston Business School, Birmingham, UK

CRC Association Conference

Case No COMP/M BANCO SANTANDER / ABBEY NATIONAL. REGULATION (EC) No 139/2004 MERGER PROCEDURE. Article 6(1)(b) NON-OPPOSITION Date: 15/09/2004

SENIOR CITIZENS ARE RIDING THE DIGITAL HEALTH WAVE

Agreements in R&D and Technology Transfer: Best Practices and Model Agreements

Report on 2 nd International Event

Research basic to Philips

Centre for the Advancement of Health Innovations (CAHI)

WRHA Supply Chain New Technology Workshop Supply Chain Forum November 17, 2010

1. Introduction. defining and producing new materials with advanced properties, or optimizing industrial processes.

Early HTA to inform value driven market access and reimbursement planning

Data users and data producers interaction: the Web-COSI project experience

Key Insight Business Briefing

Draft Plan of Action Chair's Text Status 3 May 2008

Observing Science, Technology and Innovation Studies in Russia HSE ISSEK Surveys

Report on the European Commission's Public On-line Consultation. "Shaping the ICT research and innovation agenda for the next decade"

The research commercialisation office of the University of Oxford, previously called Isis Innovation, has been renamed Oxford University Innovation

CDP-EIF ITAtech Equity Platform

Climate Change Innovation and Technology Framework 2017

Horizon 2020 Towards a Common Strategic Framework for EU Research and Innovation Funding

Standing Committee on the Law of Patents

Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework. for EU Research and Innovation Funding

NFC Forum: The Evolution of a Consortium

Advancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation

PRIMARY CARE CO-COMMISSIONING

Zayna Khayat, PhD., MaRS, Canada

Collaboration Agreement

Delivering Public Service for the Future. Tomorrow s City Hall: Catalysing the digital economy

Policy implications 15h00 16h15

On Practical Innovation Policy Learning. Per M. Koch Head of the Science Policy Project

Knowledge Sharing for Advancing EGOV Research, Policy and Practice

THE DIGITALISATION CHALLENGES IN LITHUANIAN ENGINEERING INDUSTRY. Darius Lasionis LINPRA Director November 30, 2018 Latvia

Meeting report. High Level Group on the Competitiveness of the European Chemicals Industry

CERN-PH-ADO-MN For Internal Discussion. ATTRACT Initiative. Markus Nordberg Marzio Nessi

PPP InfoDay Brussels, July 2012

European Robotics Research: Achievements and challenges

Achievements of FP7 examples that make us proud

Expectations around Impact in Horizon 2020

Societal engagement in Horizon 2020

Patient Choice and Resource Allocation Policy. NHS South Warwickshire Clinical Commissioning Group (the CCG)

Improving Access to Innovative Health Technologies. Panel Discussion ISPOR Dubai - September 20, 2018

Global strategy and plan of action on public health, innovation and intellectual property

João Cadete de Matos. João Miguel Coelho Banco de Portugal Head of the Current and Capital Accounts Statistics Unit

Draft executive summaries to target groups on industrial energy efficiency and material substitution in carbonintensive

Post : RIS 3 and evaluation

Herefordshire CCG Patient Choice and Resource Allocation Policy

2013 BUILT ENVIRONMENT MEETS PARLIAMENT QUEENSLAND

Special Feature: Acquisition of Gallaher Group PLC

Economic and Social Value of Patents in the EU

Draft submission paper: Hydrographic Offices way on EMODnet. Subject : Hydrographic Offices way on EMODnet. Foreword :

Non-ferrous metals manufacturing industry: vision for the future and actions needed

Foresight for policy-making

Four principles for selecting HCI research questions

FRAMEWORK Advances in biomedical technology are

Strategic Imperative for Networking and Partnerships in Technology Transfer

An Essential Health and Biomedical R&D Treaty

A New Platform for escience and data research into the European Ecosystem.

TRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY ACCESS TO MEDICINE: Exploitation of pharmaceutical patents: compulsory licences SESSION 4

Evidence Standards and AI

Strategic Plan Approved by Council 7 June 2010

Navigating the Healthcare Innovation Cycle

SARASOTA COUNTY GOVERNMENT

Poland: Competitiveness Report 2015 Innovation and Poland s Performance in

Preparing Europe for a new renaissance: how science can help restore sustainable prosperity

Christina Miller Director, UK Research Office

Economic and Social Council

Water, Energy and Environment in the scope of the Circular Economy

HDR UK & Digital Innovation Hubs Introduction. 22 nd November 2018

Policies for the Commissioning of Health and Healthcare

Engaging UK Climate Service Providers a series of workshops in November 2014

NHS HMR CCG and NHS England Primary Care Joint Commissioning Committee 2015/16

Why behavioural economics is essential for the success of the implementation of a wearable or health app. Behavioural Research Unit

Joint statement by. 1/ We call for a new political impetus in favour of industry at European level to face these challenges

UNCTAD Ad Hoc Expert Meeting on the Green Economy: Trade and Sustainable Development Implications November

EU businesses go digital: Opportunities, outcomes and uptake

Deliverable Report on International workshop on Networked Media R&D commercialization, Istanbul, Turkey

EUROPEAN INNOVATION PARTNERSHIP FOR ACTIVE AND HEALTHY AGEING

HealthTech in the 4IR

Consultation on Long Term sustainability of Research Infrastructures

Transcription:

Changing Healthcare Procurement Approaches in Canada and Beyond HSCN Conference 2015 May 13, 2015 Dr. Gabriela Prada Director, Health Innovation Policy The Conference Board of Canada prada@conferenceboard.ca conferenceboard.ca

Outline About the Conference Board of Canada Invention, improvement and innovation Innovation readiness in Canada s health care Procurement as an innovation lever Concluding remarks 2

About The Conference Board of Canada Objective. Independent. Evidence-based. Three principles guide us: insights, understanding, impact. What we do: research, convening, education, and dialogue. 3

Invention vs. Innovation Brand new Curiosity or inventor driven Generally results from a research process May not have real use Not necessarily new Customer driven Generally results from a business process Adds value (health, social, or economic) Key difference: execution! 4

5

Innovation: a process that extracts economic and social values from knowledge using the generation, development, and implementation of ideas to produce new or improved products, services, or processes. Source: The Conference Board of Canada 6

Improvement vs. Innovation Evolutionary: fix a process Linear process, stable Requires experts in the discipline Revolutionary: game changer Non-linear, non-stable Transdiciplinary The light bulb was not invented by improving the candle 7

Innovation Readiness in Canada s Health Care 8

Innovation Paradox The introduction of new products and processes into health systems has traditionally been perceived as a cost driver, which has prevented the adoption of innovations that can enhance health system performance and decrease overall costs. However, the manner in which innovation is procured can prove decisive in turning a burden into a substantial advantage. 9

Role of Innovation 10

Importance of Innovative Products % Reporting that Procurement Approaches in their Organizations Support the Development and Uptake of Innovative Products and Services 8.8% 29.8% 29.8% 55.0 % 45.0 % 31.6% Very important Somewhat important Yes No Important Not very important 11

Barriers for the Uptake of Innovations Rigid procurement processes and rules Lack of appropriate skills among the staff Lack of organizational interest in innovations Too much focus on cost reduction and standardization 12

Innovation Procurement in Health Care A Compelling Opportunity for Canada, July 2011 First report of its type in Canada. Opened the door for meaningful conversations about how to shift procurement from transactional processes that treat all products as commodities to a strategic tool to generate more value for health care systems. 13

14

Three Examples IMVAMUNE Kinneir Dufort and Bristol Maid Digital Hearing Aids 15

Benefits of These Approaches ü Saved lives ü Improved health care services ü Improved patient outcomes ü Enhanced patient experience and quality of life ü Reduced adverse events ü Reduced cost of care 16

Changing Procurement Practices and Policies Council for Innovation Procurement in Health Care Three international roundtables Ø Toronto, Barcelona, Moscow Innovation Procurement for Medical Devices - Driving Health System Improvement, April 2014 17

First International Roundtable: Toronto, December 2013 Seven case studies: 1. Región Hovedstaden (Denmark) 2. FARE (Italy) 3. USTDA (United States) 4. MaRS EXCITE (Canada) 5. University of Toronto (Canada) 6. HSSBC (Canada) 7. EndoCAS (Italy) 18

Second and Third International Roundtables: Barcelona and Moscow 2014 Participation from 11 countries and one international organization 1. Spain 2. Italy 3. Hungary 4. Norway 5. Portugal 6. United Kingdom 7. Russia 8. Belgium 9. Canada 10. The Netherlans 11. United States 12. Inter American Development Bank 19

Take-Away 1: Procurement Is Linked to Health Care Sustainability Agendas All countries are exploring options The European Innovation Partnership on Active and Healthy Ageing ü The SILVER (Supporting Independent LiVing for the Elderly through Robotics) ü The HAPPI (Healthy Ageing Public Procurement of Innovations) 20

Population Distribution by Age, 2012 and 2035 600,000 2012 2035 500,000 400,000 300,000 200,000 100,000 0 Sources: The Conference Board of Canada; Statistics Canada. 21

Take-Away 2: Group Perception of Value 22

Take-Away 3: Dialogue and Negotiation Enable Value-based Procurement Client-centred Negotiable RFP Competitive dialogue Ø Procuring for outcomes: Health dialysis solution by Health Shared Services BC Ø Procuring for solutions: Cardiac services at Imperial College Healthcare NHS 23

Procuring for Outcomes: Peritoneal Dialysis Program by Health Shared Services BC HSSBC was established in 2009 to centralize the purchasing power of the BC Health Authorities. The program assists over 850 patients with kidney failure to perform dialysis at home on their own. Patients contact the vendor call centre to order supplies and arrange for delivery, and the vendor provides frontline patient support and liaison with care providers. Benefits: regional flexibility, new technology, one-stop-shop, value-add requirements (volume rebates, training opportunities). Results: costs dropped as a result of negotiated volume rebates, even as usage increased. Clinicians have more choice and flexibility to introduce clinical innovation. Patient experience has improved. Services have also subsequently improved by expanding call centre hours and support and adding delivery options for international travel. 24

Procuring for Solutions: Cardiac Services at Imperial College Healthcare NHS Approx value 70m: Full refurbishment of all five labs over the 7 years; 2942 stock lines and 12,436 items; 2.7 million inventory Fully refurbished two labs in 2013; 3 further planned for 2015/16 Vendor assumed full responsibility for provision, commissioning, and maintenance of capital equipment Determined appropriate equipment needs and coverage level for all items Developed a Quality Framework equipment management Results to date: 100% lab uptime from new equipment; Increased maintenance cover and weekend preventative visits allowing labs to run at full capacity; potential revenue increase of 100K; efficiency gains: 18% increase in number of cases performed; 14% increase in cathlab utilization. 25

Take-Away 4: Success Requires Systemic Efforts 26

Take-Away 5: Clinician and Patient Engagement Is Key for Innovation Procurement Clinicians and patients are not only the recipients and users of innovative health care technologies, but they are an important source of ideas to improve or develop innovations and they are essential in the evaluation of innovations. 27

Glossary Pre-commercial procurement (or Public Procurement of Research and Development): used when there is a perceived need without a commercially available solution. In this case, procurement is an R&D service contract with multi stage process that ranges from exploration and feasibility to prototyping, field tests, and commercialisation. Key that WTO Agreement and EU Procurement Directives do not apply. Innovation procurement: specifying a requirement that cannot be met by an off-theshelf solution but it can be developed within a reasonable period of time. Innovation procurement stimulates innovative private procurement (by catalysing private demand lead user), which bring economic and societal benefits. Procurement of innovation: using procurement processes to speed up adoption and diffusion of innovative products (which add value to organizations and health care systems) that already exists but are not widely adopted. Innovative procurement: use of new methods, models, or technologies to enhance procurement processes and increase value for money. 28

Closing Remarks When used correctly, procurement processes are a powerful tool to introduce innovation and improvement within health systems. Emerging procurement models are proving better than traditional approaches in enhancing quality and value for money. Change requires engagement, awareness, education, and patience. It is necessary to step up to the plate! 29

conferenceboard.ca